Daily Archives: January 20, 2022
Booster longevity: Data reveals how long a third shot protects.
20 Jan, 2022 | 09:33h | UTCBooster longevity: Data reveals how long a third shot protects – NPR
Original Report: SARS-CoV-2 variants of concern and variants under investigation in England – U.K. Health Security Agency
A populational-based retrospective cohort study in Qatar showed a reduced risk of Covid-19 breakthrough infections with the Moderna vs. the Pfizer–BioNTech vaccine.
20 Jan, 2022 | 09:30h | UTCEffectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar – New England Journal of Medicine
Commentary on Twitter
In two matched retrospective cohort studies comparing BNT162b2 and mRNA-1273, both were highly effective at preventing hospitalization & death. Breakthrough infections were lower among those who received mRNA-1273 than those who received BNT162b2. https://t.co/wgkrzfLNHz pic.twitter.com/E8hXIDFqWW
— NEJM (@NEJM) January 19, 2022
Heart function recovered quickly in children with COVID-19-related multisystem inflammatory syndrome (MIS-C).
20 Jan, 2022 | 09:26h | UTCNews Release: Heart function recovered quickly in children with COVID-19-related MIS-C condition – American Heart Association
Short Review: Fluvoxamine for symptomatic outpatients with COVID-19.
20 Jan, 2022 | 09:25h | UTCFluvoxamine for symptomatic outpatients with COVID-19 – Canadian Medical Association Journal
Related:
Fluvoxamine for Covid-19: What Prescribers and Pharmacists Need to Know.
Fluvoxamine for the early treatment of SARS-CoV-2 Infection: a review of current evidence.
Milder disease with Omicron: is it the virus or the pre-existing immunity?
20 Jan, 2022 | 09:28h | UTC
How does Omicron spread so fast? A high viral load isn’t the answer – “Data on viral levels point to immune evasion as a cause of the variant’s transmissibility”.
20 Jan, 2022 | 09:27h | UTCHow does Omicron spread so fast? A high viral load isn’t the answer – Nature
A large observational study showed people with immune disfunction (HIV, solid organ transplant, rheumatoid arthritis) were at increased risk of breakthrough Covid-19 infection after vaccination.
20 Jan, 2022 | 09:24h | UTC
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
20 Jan, 2022 | 09:17h | UTCGlobal burden of bacterial antimicrobial resistance in 2019: a systematic analysis – The Lancet
Editorial: Antimicrobial resistance: time to repurpose the Global Fund – The Lancet
Commentary: Antimicrobial resistance now a leading cause of death worldwide, study finds – The Guardian
Commentary on Twitter
NEW—An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections, more deaths than HIV/AIDS or malaria.#GRAMPaper reveals the scale of antimicrobial resistance (#AMR), now a leading cause of death worldwide: https://t.co/2h5UEKemEq #AMRSOS pic.twitter.com/aWLhmdirJ8
— The Lancet (@TheLancet) January 20, 2022
10 lessons I’ve learned from the Covid–19 pandemic.
20 Jan, 2022 | 09:21h | UTC10 lessons I’ve learned from the Covid–19 pandemic – STAT
Covid pandemic ‘nowhere near over,’ WHO says.
20 Jan, 2022 | 09:18h | UTCCovid pandemic ‘nowhere near over,’ WHO says – CNN
After Omicron, we could use a break. We may just get it.
20 Jan, 2022 | 09:21h | UTCAfter Omicron, we could use a break. We may just get it – STAT
RCT: Among patients with recurrent Clostridioides difficile infection, the use of SER-109, an oral microbiome therapy, reduced recurrence rate compared to placebo (12% vs. 40%).
20 Jan, 2022 | 09:11h | UTCSER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection – New England Journal of Medicine (link to abstract – $ for full-text)
1.8 million excess deaths attributable to urban air pollution in 2019, modelling study suggests.
20 Jan, 2022 | 09:13h | UTCNews Release: The Lancet Planetary Health: 1.8 million excess deaths attributable to urban air pollution in 2019, modelling study suggests
Related Studies:
Commentary on Twitter (thread – click for more)
NEW—Approx. 86% of people living in urban areas exposed to unhealthy particulate matter levels, leading to 1.8 million excess deaths in 2019: modelling study in @TheLancetPlanet. #AirPollutionhttps://t.co/kw34ANZ4ph
Thread ? pic.twitter.com/QiRXU4QVHP
— The Lancet (@TheLancet) January 6, 2022
RCT: In very young children with Type 1 Diabetes, a hybrid closed-loop therapy (“artificial pancreas”) resulted in better glycemic control without increased risk of hypoglycemia vs. sensor-augmented pump therapy.
20 Jan, 2022 | 09:07h | UTCRandomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)
M-A: the accuracy of serological tests to support the diagnosis of celiac disease.
20 Jan, 2022 | 09:02h | UTC
Meta-analysis of randomized controlled trials: Drug treatment for panic disorder with or without agoraphobia.
20 Jan, 2022 | 09:06h | UTC
Study shows that the retinal age gap might be a potential biomarker of aging linked to increased mortality risk.
20 Jan, 2022 | 09:04h | UTCRetinal age gap as a predictive biomarker for mortality risk – British Journal of Ophthalmology (link to abstract – $ for full-text)
News Release: Difference between retina’s biological age and person’s real age linked to heightened death risk – BMJ
Commentary on Twitter
Difference between retina’s biological age and person’s real age linked to heightened death risk finds @BMJ_Ophth study https://t.co/TNveo5E77D
— BMJ (@bmj_company) January 19, 2022
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update.
20 Jan, 2022 | 08:57h | UTC
Commentary on Twitter
Out on @JCO_ASCO the new ASCO/OH guidelines for adjuvant bisphosphonates in BC
Important to weight risks and benefits based on the risk profile of the disease, financial toxicity, drug availability, patient preferences, comorbidities & life expectancy. https://t.co/6noyYplALB
— Paolo Tarantino (@PTarantinoMD) January 18, 2022
Systematic Review: Prevalence, incidence and survival of heart failure.
20 Jan, 2022 | 09:00h | UTCPrevalence, incidence and survival of heart failure: a systematic review – Heart
O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee.
20 Jan, 2022 | 08:59h | UTC
Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis.
20 Jan, 2022 | 08:52h | UTC
Review: Evaluating the patient with a pulmonary nodule.
20 Jan, 2022 | 08:56h | UTCEvaluating the Patient With a Pulmonary Nodule: A Review – JAMA (free for a limited period)
Author Interview: Evaluation and Management of Patients With Pulmonary Nodules
Consensus Statement: Exercise/physical activity in individuals with Type 2 Diabetes.
20 Jan, 2022 | 08:51h | UTC
Commentary from the author on Twitter
Exercise/Physical Activity in Individuals with
Type 2 Diabetes: A Consensus Statement from
the American College of Sports Medicine
Honored to contribute w/several esteemed colleagues to this report now out on #exercise & #diabetes @MSSEonline @ACSMNews https://t.co/UNmoU2BgLR— Juleen R. Zierath (@JuleenRZierath) January 14, 2022
Review: Diagnosis and treatment of polycystic ovary syndrome.
20 Jan, 2022 | 08:54h | UTCDiagnosis and Treatment of Polycystic Ovary Syndrome – JAMA (free for a limited period)
How do we make decisions for the most immature babies, with their families?
20 Jan, 2022 | 08:49h | UTCHow do we make decisions for the most immature babies, with their families? – Neonatal Research